Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Mutation Research|July 1, 1983
Induction of chromosomal alterations as an assay for cytostatic drug activity in plasmaA T Natarajan, E A de Bruijn, P Leeflang, et al.Cancer Research|November 1, 1985
Pharmacology of 5'-deoxy-5-fluorouridine in patients with resistant ovarian cancerE A de Bruijn, A T van Oosterom, U R Tjaden, et al.Amino Acids|November 19, 2004
Differential protein expression profile in gastrointestinal stromal tumorsB Landuyt, H Prenen, M Debiec-Rychter, et al.Anti-Cancer Drugs|July 1, 1996
The influence of hypoxia on the cytotoxicity of concomitant KW-2149 and ionizing irradiation in Chinese hamster fibroblastsA Egelmeers, L Y Dirix, J Lyczek, et al.Journal of Pharmaceutical Sciences|October 1, 1988
Behavior and resorption of mitomycin C following multiple intravesical administrationsP J van Helsdingen, E A de Bruijn, H P Sleeboom, et al.Cancer Treatment Reports|December 1, 1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal modelE A de Bruijn, O Driessen, P Leeflang, et al.Biochemical Pharmacology|March 8, 1996
Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adductsC M De Pooter, A T Van Oosterom, P G Scalliet, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicitiesM Barberi-Heyob, B Weber, J L Merlin, et al.Anti-Cancer Drugs|December 24, 1997
In vitro toxicity studies with mitomycins and bleomycin on endothelial cellsL Y Dirix, M Libura, J Libura, et al.Anti-Cancer Drugs|June 1, 1994
Cytotoxic activity of 7-N-(2-((2-(-gamma-L-glutamylamino)- ethyl)dithio)ethyl)-mitomycin C and metabolites in cell lines with different resistance patternsL Y Dirix, E E Gheuens, S van der Heyden, et al.Pageof 9